The same group has recently developed a bivalent 111In-DOTA-labeled antibody to MUC-1 and reported on successful gamma scintigraphy results in mice bearing s.c. xenografts of pancreatic carcinoma [31]. Here, MUC1 is linked to exocrine pancreatic carcinoma.